LONDON--(BUSINESS WIRE)--
Ap19
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
| Name of person dealing (Note 1) | Barclays PLC. | |
| Company dealt in | UDG HEALTHCARE PLC | |
| Class of relevant security to which the | ORD | |
| dealings being disclosed relate (Note 2) | ||
| Date of dealing | 02 June 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) |
Relevant securities | ||||
5,299,941 |
2.10% |
88,491 |
0.04% |
||
|
|
|
|
||
(2) |
Derivatives (other than options): |
|
|
|
|
48,822 |
0.02% |
4,839,505 |
1.92% |
||
|
|
|
|
||
(3) |
Options and agreements to |
|
|
|
|
| purchase/sell: | 0 |
0.00% |
0 |
0.00% |
|
|
|
|
|
||
| TOTAL: |
|
|
|
|
|
5,348,763 |
2.12% |
4,927,996 |
1.96% |
||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: |
Long |
Short |
||||
|
Number |
|
(%) |
Number |
|
(%) |
(1) Relevant securities |
|
|
||||
(2) Derivatives (other than options) |
|
|
||||
(3) Options and agreements to purchase/sell |
|
|
||||
Total |
|
|
||||
|
||||||
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
Purchase |
138 |
10.5647 GBP |
Purchase |
149 |
10.5618 GBP |
Purchase |
187 |
10.5579 GBP |
Purchase |
854 |
10.5600 GBP |
Purchase |
1,839 |
10.5645 GBP |
Purchase |
2,061 |
10.5696 GBP |
Purchase |
2,966 |
10.5500 GBP |
Purchase |
16,201 |
10.5700 GBP |
Purchase |
26,460 |
10.5504 GBP |
Purchase |
27,291 |
10.6038 GBP |
Purchase |
27,494 |
10.5530 GBP |
Purchase |
29,733 |
10.5522 GBP |
Purchase |
30,880 |
10.5529 GBP |
Purchase |
139,592 |
10.5612 GBP |
Purchase |
141,142 |
10.5559 GBP |
Sale |
559 |
10.5547 GBP |
Sale |
839 |
10.5672 GBP |
Sale |
1,171 |
10.5619 GBP |
Sale |
1,220 |
10.5378 GBP |
Sale |
1,425 |
10.5699 GBP |
Sale |
1,629 |
10.5600 GBP |
Sale |
1,667 |
10.5530 GBP |
Sale |
2,096 |
10.5429 GBP |
Sale |
2,419 |
10.5527 GBP |
Sale |
3,518 |
10.5888 GBP |
Sale |
3,541 |
10.5689 GBP |
Sale |
3,664 |
10.5735 GBP |
Sale |
3,691 |
10.5700 GBP |
Sale |
6,352 |
10.5659 GBP |
Sale |
6,439 |
10.5626 GBP |
Sale |
7,467 |
10.5478 GBP |
Sale |
8,145 |
10.5532 GBP |
Sale |
8,766 |
10.5593 GBP |
Sale |
11,423 |
10.5500 GBP |
Sale |
11,943 |
10.5705 GBP |
Sale |
12,192 |
10.5643 GBP |
Sale |
39,021 |
10.5876 GBP |
Sale |
91,347 |
10.5649 GBP |
Sale |
224,095 |
10.5524 GBP |
(b) Derivatives transactions (other than options transactions)
| Product Name | Nature of transaction | Number of relevant securities | Price per |
| unit | |||
CFD |
Long |
6,805 |
10.5485 GBP |
SWAP |
Long |
10,897 |
10.5626 GBP |
SWAP |
Long |
11,643 |
10.5701 GBP |
SWAP |
Long |
14,471 |
10.5577 GBP |
CFD |
Short |
1,839 |
10.5645 GBP |
SWAP |
Short |
4,394 |
10.5602 GBP |
SWAP |
Short |
5,465 |
10.5553 GBP |
SWAP |
Short |
23,305 |
10.5706 GBP |
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option |
Writing, selling, purchasing, varying etc. |
Number of securities to which the option relates (Note 7) |
Exercise price |
Type, e.g. American, European etc. |
Expiry date |
Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option |
Number of securities |
Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) |
Details |
Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
| Is a Supplemental Form 8 (Open Positions) attached? | NO |
| Date of disclosure: | 3 Jun 2021 |
| Contact name: | Large Holdings Regulatory Operations |
| Telephone number: | 020 3134 7213 |
| If a connected EFM, name of offeree/offeror with which connected | |
| If a connected EFM, state nature of connection |